Clicky

Pasithea Therapeutics Corp.(KTTA)

Description: Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.


Keywords: Biotechnology Drugs Pharmacy Psychoactive Drugs Neurochemistry Business Support Services Antidepressants Ketones Ketamine Sedatives Psychiatric And Neurological Disorders Intravenous Infusions Arylcyclohexylamines

Home Page: www.pasithea.com

KTTA Technical Analysis

1111 Lincoln Road
Miami Beach, FL 33139
United States
Phone: 702 514 4174


Officers

Name Title
Dr. Lawrence Steinman BA, M.D. Exec. Chairman & Co-Founder
Dr. Tiago Reis Marques CEO & Director
Mr. Daniel H. Schneiderman Chief Financial Officer
Dr. Yassine Bendiabdallah Ph.D. COO & Head of UK Clinics

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.6064
Price-to-Sales TTM: 93.068
IPO Date: 2021-09-15
Fiscal Year End: December
Full Time Employees: 3
Back to stocks